New imaging technique reveals green tea Extract's effect on scarred lungs
NCT ID NCT06265532
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a new type of PET scan can measure how the supplement EGCG (found in green tea) affects collagen buildup in the lungs of people with idiopathic pulmonary fibrosis (IPF). Twelve participants who were already in a larger EGCG study received an injection of a special probe that lights up collagen during the scan. The goal was to see if the scan could detect changes in lung collagen and help choose the right dose of EGCG.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Virginia
Charlottesville, Virginia, 22908, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What makes someone stop a lung fibrosis drug? a study asks patients directly
- A smarter way to track lung disease? new platform aims to personalize COPD and IPF care
- AI outruns radiologists in detecting early lung scarring
- Experimental drug aims to slow lung scarring in IPF
- AI-Designed drug targets scarred lungs in major trial
- Can scans replace breathing tests to monitor lung scarring?